Andere Sprachen iBio, Inc.

Aktien

A3E2GR

US4510337086

IBIO

Markt geschlossen - Nyse Andere Börsenplätze 22:00:00 24.04.2024			% 5 Tage	% 1. Jan.
1,9 ^USD	0,00 %		+0,53 %	+38,69 %

28.03.	Top Premarket Gainers	MT
27.03.	Top Mittagsgewinner	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

IBio, Inc. announced that it has received $15.066157 million in funding from ADAR1 Capital Management, LLC, Lynx1 Capital Management LP, Ikarian Capital, LLC and other investors	01.04.
Top Premarket Gainers	28.03.
Top Midday Gainers	27.03.
Wall Street Set to Open Higher Wednesday as Investors Eye End-of-Week Economic, Inflation Data	27.03.
US Futures Trend Higher Wednesday Pre-Bell as Investors Eye Impending Economic, Inflation Data Readings	27.03.
Top Premarket Gainers	27.03.
IBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases	27.03.
IBio, Inc. and AstralBio, Inc. Announce Transformative AI Drug Discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases	27.03.
IBio Announces $15.0 Million Private Placement	27.03.
IBio, Inc. announced that it has received $14 million in funding	26.03.
IBio Sells Preclinical PD-1 Antagonist Antibody Program to Otsuka	26.02.
IBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka	26.02.
Otsuka Pharmaceutical Co., Ltd. completed the acquisition of Preclinical PD-1 Agonist Antibody Program of iBio, Inc..	25.02.
IBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	09.02.
IBio Announces Participation in 23rd Annual PepTalk Conference	16.01.
IBio Amends and Extends Maturity of Credit Agreement	26.12.
Top Midday Decliners	05.12.
IBio, Inc. Announces Pricing of $4.5 Million Public Offering	05.12.
Top Premarket Decliners	05.12.
North American Morning Briefing : November Rally Pauses Ahead of This Week's PCE Report	28.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen iBio, Inc.

Aktien

A3E2GR

US4510337086

IBIO

Andere Sprachen

Filter